Neonc (NTHI) news
Recent news
NeonC Technologies - Q2 2026 net loss $14.20 mln or $(0.58) per diluted share
NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) reported a net loss of $14.2 million, or $(0.58) per diluted share, for the second quarter of 2026, compared to net loss of $5.7 million , or $(0.30) per diluted share, in the same period in 2025. The increase in the net loss was primarily driven by…
AInvest Wire · Aug 10, 2026NeonC reports second quarter 2026 financial results and confirms August 12 topline Phase 2A NEO100 data readout
AInvest Wire · Aug 10, 2026Neonc Technologies appoints strategy and finance executive Nasim Shomali to its board of directors
AInvest Wire · Jul 27, 2026Neonc Technologies - to update Neo212 development plan after incorporating FDA feedback
AInvest Wire · Jul 15, 2026NeonC Technologies - cancels July 9 FDA meeting after sufficient written responses
NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) has canceled a previously scheduled July 9, 2026, meeting with the U.S. Food and Drug Administration (FDA) following the submission of sufficient written responses to address the agency’s questions. The decision reflects the company’s belief that…
AInvest Wire · Jul 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.